CYB5R3 T117S tempers fetal hemoglobin induction by hydroxyurea in patients with sickle cell disease
Saved in:
| Main Authors: | Fabliha A. Chowdhury, Malini Sharma, Desiree Schafer, Seyed M. Nouraie, Mark T. Gladwin, Adam C. Straub, Katherine C. Wood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924006001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyurea Treatment for Sickle Cell Disease
by: Martin H. Steinberg
Published: (2002-01-01) -
The modern use of hydroxyurea for children with sickle cell anemia
by: Charles T. Quinn, et al.
Published: (2025-01-01) -
Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
by: Mohammed Ali Al Sabbah, et al.
Published: (2023-07-01) -
Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy
by: Gabriela Araujo de Abreu, et al.
Published: (2024-11-01) -
Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)